October 12, 2020 -- InvestorsHub NewsWire -- via The Stock Investing Group -- Now that several states are finally starting to legitimize the sale of marijuana and hemp-related products, including the ever so useful CBD, it is well worth the investment into players that have a strong foundation and will continue to have the sales, the cash flow, and the ability to grow with the industry that continues its expanse.  CBD Unlimited has been a major player in the CBD and pot stock sector since its beginnings in 2013.  Many others have attempted to enter the CBD market with varying success; however, Endexx Corporation(EDXC) trading under the brand name of CBD Unlimited has been steadily growing.  

Their CBD products, which are not under the same legal restrictions as many cannabis products, have now already made it into over 5,000 retail locations.  These are just the beginning as their high-quality products will further expanded their retail reach to the end of 2020, with the new distribution contracts signed, including one with Wallgreens hoping to increase this to 20,000 total locations.  CBD Unlimited is now expected to grow its year on year sales from 2019’s $1M, to an expected $20M in annual revenues by 2021.  Even during COVID-19, CBD Unlimited saw over $1 million in sales during the second quarter of 2020.  If this is the case, we suspect that the stock price can have a similar rise to sales going from its current $0.06 to an expected $0.80 in 12 months.

The good news does not stop with these revenue projections, there have been two rumors of new projects floating around for a while, and we can now confirm one of them.  The first of which that can be confirmed is that CBD Unlimited is making its move into the exciting Pet Health sector.  A recent Chicago Tribune article stated that New Mexico, California, and New York are all considering the use of medical cannabis for pets.  These moves of early adoption are signs of the legitimacy for pot-related products having a place in pet health.  

Packaged Facts a retail industry researcher, found that Americans spent $33 billion on pet food and treats in 2018, and they estimated that just pet treat sales in the U.S. reached $6.7 billion in 2019, a year-over-year rise of 31%, with an expectation that the market will continue to grow 2.8% annually until 2023.  According to Nielsen and Headset’s 2020 Pet Industry Green Paper, hemp-based CBD pet products will represent 3%-5% of all hemp CBD sales within the U.S.  These are great signs for CBD Unlimited, the current Pet CBD market is already saturated with numerous tinctures, however is still in its infancy for the more pet desirable chews, where CBD unlimited’s products compete.  

The second bit of news which still remains in the rumor mill and has yet to be confirmed is that CBD Unlimited has in the works “something going on in Jamaica”.  We don’t know exactly what this Jamaican rumor might be, but it sure seems to make the company representatives quite excited.  

We are now recommending Endexx Corporation(EDXC) as a strong buy.  The fundamentals continue to look good, and they are consistently growing their sales at a sustainable rate with promising advances on the horizon.  

SOURCE: The Stock Investing Group